SEARCH

SEARCH BY CITATION

References

  • 1
    Saheki T, Kobayashi K, Inoue I. Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol 1987; 108: 2168.
  • 2
    McKusick VA, Francomano CA, Antonarakis SE, Pearson PL. Citrul-linemia. In: McKusickVA, ed. Mendelian Inheritance in Man. Baltimore: Johns Hopkins University Press, 1994: 17061708.
  • 3
    Brusilow SW, Horwich AL. Urea cycle enzymes. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The Metabolic and Molecular Bases of Inherited Disease. Ed 7. New York: McGraw-Hill, 1995: 11871232.
  • 4
    Saheki T, Kobayashi K, Ichiki H, Matuo S, Tatsuno M, Imamura Y, Inoue I, et al. Molecular basis of enzyme abnormalities in urea cycle disorders: with special reference to citrullinemia and argininosuccinic aciduria. Enzyme 1987; 38: 227232.
  • 5
    Kobayashi K, Shaheen N, Kumashiro R, Tanikawa K, O'Brien WE, Beaudet AL, Saheki T. A search for the primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet 1993; 53: 10241030.
  • 6
    Kobayashi K, Ichiki H, Saheki T, Tatsuno M, Uchiyama C, Nukada O, Yoda T. Structure of an abnormal messenger RNA for argininosuccinate synthetase in citrullinemia. Hum Genet 1987; 76: 2732.
  • 7
    Jackson MJ, Kobayashi K, Beaudet AL, O'Brien WE. Analysis of deletions at the human argininosuccinate synthetase locus. Mol Biol Med 1989; 6: 179186.
  • 8
    Kobayashi K, Jackson MJ, Tick DB, O'Brien WE, Beaudet AL. Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J Biol Chem 1990; 265: 1136111367.
  • 9
    Kobayashi K, Rosenbloom C, Beaudet AL, O'Brien WE. Additional mutations in argininosuccinate synthetase causing citrullinemia. Mol Biol Med 1991; 8: 95100.
  • 10
    Kobayashi K, Shaheen N, Terazono H, Saheki T. Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. Am J Hum Genet 1994; 55: 11031112.
  • 11
    Kobayashi K, Kakinoki H, Fukushige T, Shaheen N, Terazono H, Saheki T. Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia. Hum Genet 1995; 96: 454463.
  • 12
    Kakinoki H, Kobayashi K, Terazono H, Nagata Y, Saheki T. Mutations and DNA diagnoses of classical citrullinemia. Hum Mutat 1997; 9: 250259.
  • 13
    Sase M, Kobayashi K, Imamura Y, Saheki T, Nakano K, Miura S, Mori M. Level of translatable messenger RNA coding for argininosuccinate synthetase in the liver of the patients with quantitative-type citrullinemia. Hum Genet 1985; 69: 130134.
  • 14
    Kobayashi K, Saheki T, Imamura Y, Noda T, Inoue I, Matuo S, Hagihara S, et al. Messenger RNA coding for argininosuccinate synthetase in citrullinemia. Am J Hum Genet 1986; 38: 667680.
  • 15
    Todo S, Starzl TE, Tzakis A, Benkov KJ, Kalousek F, Saheki T, Tanikawa K, et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992; 15: 419422.
  • 16
    Yazaki M, Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Kawasaki S, et al. Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation. Transplantation 1996; 62: 16791681.
  • 17
    Kawamoto S, Strong RW, Kerlin P, Lynch SV, Steadman C, Kobayashi K, Nakagawa S, et al. Orthotopic liver transplantation for adult-onset type II citrullinaemia. Clin Transplant 1997; in press.
  • 18
    Kobayashi K, Nakata M, Terazono H, Shinsato T, Saheki T. Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia. FEES Lett 1995; 372: 6973.
  • 19
    Pezzilli R, Billi P, Plate L, Barakat B, Bongiovanni F, Miglioli M. Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis: a comparison with C-reactive protein. J Clin Gastroen-terol 1994; 19: 112117.
  • 20
    Matsuda K, Ogawa M, Murata A, Kitahara T, Kosaki G. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res Commun Chem Pathol Pharmacol 1983; 40: 301305.
  • 21
    Ogawa M, Tomita N, Horii A, Matsuura N, Higashiyama M, Yamamoto T, Murata A, et al. Pancreatic secretory trypsin inhibitor in cancer. Adv Exp Med Biol 1988; 240: 547553.
  • 22
    Ohmachi Y, Murata A, Matsuura N, Yasuda T, Yasuda T, Monden M, Mori T, et al. Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int J Cancer 1993; 55: 728734.
  • 23
    Ogawa M. Pancreatic secretory trypsin inhibitor as an acute phase re-actant. Clin Biochem 1988; 21: 1925.
  • 24
    Ogawa M. Pancreatic secretory trypsin inhibitor (PSTI) [in Japanese]. Nippon Rinsho 1995; 53: 317322.
  • 25
    Saheki T, Kobayashi K, Miura T, Hashimoto S, Ueno Y, Yamasaki T, Araki H, et al. Serum amino acid pattern of type II citrullinemic patients and effect of oral administration of citrulline. J Clin Biochem Nutr 1986; 1: 129142.
  • 26
    Yagi Y, Saheki T, Imamura Y, Kobayashi K, Sase M, Nakano K, Matuo S, et al. The heterogeneous distribution of argininosuccinate synthetase in the liver of type II citrullinemic patients: its specificity and possible clinical implications. Am J Clin Pathol 1988; 89: 735741.
  • 27
    Saheki T, Ueda A, Hosoya M, Kusumi K, Takada S, Tsuda M, Katsunuma T. Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. Clin Chim Acta 1981; 109: 325335.
  • 28
    Su T-S, Bock H-GO, Beaudet AL, O'Brien WE. Molecular analysis of argininosuccinate synthetase deficiency in human fibroblasts. J Clin Invest 1982; 70: 13341339.
  • 29
    Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. J Am Chem Soc 1948; 70: 30343040.
  • 30
    Greene LJ, Pubols MH, Bartelt DC. Human pancreatic secretory trypsin inhibitor. Methods Enzymol 1976; 45: 813825.
  • 31
    Tomita N, Horii A, Yamamoto T, Ogawa M, Mori T, Matsubara K. Expression of pancreatic secretory trypsin inhibitor gene in neoplastic tissues. FEBS Lett 1987; 225: 113119.
  • 32
    Higashiyama M, Monden T, Ogawa M, Matsuura N, Murotani M, Kawasaki Y, Tomita N, et al. Immunohistochemical study on pancreatic secretory trypsin inhibitor (PSTI) in gastric carcinomas. Am J Clin Pathol 1990; 93: 813.
  • 33
    Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R, Matsuura N, Murata A, et al. Immunohistochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: its possible participation in scar formation of the tumor tissues. Tumor Biol 1992; 13: 299307.
  • 34
    Hunt LT, Barker WC, Dayhoff MO. Epidermal growth factor: internal duplication and probable relationship to pancreatic secretory trypsin inhibitor. Biochem Biophys Res Commun 1974; 60: 10201028.
  • 35
    McKeehan WL, Sakagami Y, Hoshi H, McKeehan KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 1986; 261: 53785383.
  • 36
    Ogawa M, Tsushima T, Ohba Y, Ogawa N, Tanaka S, Ishida M, Mori T. Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor. Res Commun Chem Pathol Pharmacol 1985; 50: 155158.
  • 37
    Niinobu T, Ogawa M, Murata A, Nishijima J, Mori T. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor. J Exp Med 1990; 172: 11331142.
  • 38
    Freeman TC, Curry BJ, Calam J, Woodburn JR. Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells. Gas-troenterology 1990; 99: 14141420.
  • 39
    Ohmachi Y, Murata A, Matsuura N, Yasuda T, Uda K, Mori T. Overex-pression of pancreatic secretory trypsin inhibitor in pancreatic cancer: evaluation of its biological function as a growth factor. Int J Pancreatol 1994; 15: 6573.
  • 40
    Yasuda T, Ogawa M, Murata A, Oka Y, Uda K, Mori T. Response to IL- 6 stimulation of human hepatoblastoma cells: production of pancreatic secretory trypsin inhibitor. Biol Chem Hoppe-Seyler 1990; 371: 95100.
  • 41
    Yasuda T, Ogawa M, Murata A, Ohmachi Y, Yasuda T, Mori T, Matsubara K Identification of the IL-6-responsive element in an acute-phase-responsive human pancreatic secretory trypsin inhibitor-encoding gene. Gene 1993; 131: 275280.
  • 42
    Ohmachi Y, Murata A, Yasuda T, Kitagawa K, Yamamoto S, Monden M, Mori T. et al. Expression of the pancreatic secretory trypsin inhibitor gene in the liver infected with hepatitis B virus. J Hepatol 1994; 21: 0121015.
  • 43
    Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immu-nol Today 1994; 15: 8188.